Publicaciones en colaboración con investigadores/as de Christie Hospital NHS Foundation Trust (10)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2011

  1. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials

    The Lancet, Vol. 378, Núm. 9793, pp. 771-784

  2. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials

    The Lancet, Vol. 378, Núm. 9793, pp. 771-784

2009

  1. The cancer survival gap between elderly and middle-aged patients in Europe is widening

    European Journal of Cancer, Vol. 45, Núm. 6, pp. 1006-1016

2001

  1. A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 230

1997

  1. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

    Immunology Today, Vol. 18, Núm. 2, pp. 89-95

  2. Integration of high-risk human papillomavirus DNA is linked to the down- regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells

    Cancer Research, Vol. 57, Núm. 5, pp. 937-942

1992

  1. HLA Class II Antigen Expression in Human Papillomavirus-associated Cervical Cancer

    Cancer Research, Vol. 52, Núm. 14, pp. 4009-4016